Henry Schein | HSIC - Cash And Equivalent


Henry Schein reported $136M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cigna USD 6.02B 1.7B Sep/2025
Concord Medical Services Hldg CNY 243.38M 85.1M Jun/2023
Cooper Companies USD 124.9M 13.3M Jun/2025
CVS Health USD 8.45B 645M Dec/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Encompass Health USD 72.2M 23.5M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Owens Minor USD 281.99M 249.15M Dec/2025
Quest Diagnostics USD 420M 12M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Tenet Healthcare USD 2.88B 92M Dec/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Universal Health Services USD 112.9M 24.7M Sep/2025
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025
Zoetis USD 2.08B 649M Sep/2025